Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Top Growth Stock Set to Crush the Market Again in 2023


Last year, biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) did not disappoint its shareholders. The drugmaker put up an impressive performance that easily exceeded that of the broader market. But that was last year.

The good news for investors is that the company has developments that could lead to a similarly strong showing in 2023. And even at current levels, Vertex is an excellent biotech stock to buy. Let's look into why the drugmaker is such a solid company to invest in now.

VRTX data by YCharts.

Continue reading


Source Fool.com

Like: 0
Share

Comments